Hokkaido, Japan

Masahito Nakazaki

This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Nipro Corporation, Sapporo Medical University. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahito Nakazaki. Retrieved from https://idiyas.com/inventor/masahito-nakazaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masahito Nakazaki: Innovator in Synapse Formation

Introduction

Masahito Nakazaki is a prominent inventor based in Hokkaido, Japan. He is known for his significant contributions to the field of neuroscience, particularly in the development of agents that promote synapse formation and brain plasticity. His work has implications for treating various neurological conditions.

Latest Patents

Masahito Nakazaki holds a patent for a synapse formation agent. This invention relates to a synapse formation promoter and a brain plasticity promoter comprising CD24-negative mesenchymal stem cells prepared from a patient's own bone marrow aspirate. The treatment targets conditions such as dementia, chronic-phase cerebral infarction, chronic-phase spinal cord injury, and mental diseases.

Career Highlights

Throughout his career, Nakazaki has worked with esteemed institutions, including Sapporo Medical University and Nipro Corporation. His research has been pivotal in advancing the understanding of brain plasticity and its potential therapeutic applications.

Collaborations

Some of his notable coworkers include Osamu Honmou and Masanori Sasaki. Their collaborative efforts have contributed to the success of Nakazaki's research and innovations.

Conclusion

Masahito Nakazaki's work in developing synapse formation agents showcases his dedication to advancing medical science. His contributions have the potential to significantly impact the treatment of neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…